A cancer biologist-turned angel investor, with 25 years of cross-functional experience in drug development, regulatory affairs, grants & angel investing, within academia & industry.
Our MEDA Angels investor group was co-founded by physician colleagues & myself, with the mission of investing in high-impact healthcare startups. We invest liberally in all types, including digital health, med device, wellness, AI, VR/AR & robotics. Therapeutics is limited to repurposed drugs.
Elizabeth is attending / has attended:
The 2019 New England Venture Summit
Venture Summit Virtual Connect | Global